-
Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance
Tuesday, November 9, 2021 - 6:56pm | 744Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a global biopharmaceutical company, announced its financial results Tuesday afternoon for the third quarter of 2021 and updated financial guidance for 2021. "Last year, we set the ambitious corporate objective of completing five key commercial...